Kazuo Asakawa
Representative Director
Executive Vice President Chief Operating Officer Head of the
Symbio AB
Australia
Biography
Kazuo Asakawa graduated from the Faculty of Engineering, Chiba Institute of Technology, in 1977, and subsequently completed a Master's degree in Industrial Chemistry at the Graduate School of Engineering of the university, and then joined Sandoz Japan K.K. He successively held various important positions such as General Manager, Central Nervous System Unit, Nippon Roche K.K. (1994), Group Manager, Special Products Group, Sandoz Japan K.K. (1997), General Manager, Marketing Department, Novartis Pharma K.K. (1997), Corporate Officer, Head of Transplantation & Immunology Business Division, Novartis Pharma K.K. (2002), and Executive Director, Head of Oncology Business Unit, Novartis Pharma K.K. (2005). He joined SymBio Pharmaceuticals Limited in December 2015 as Head of the Japan Business Unit of the Company, and assumed the position of Corporate Officer, Executive Vice President; Chief Operating Officer and Head of the Japan Business Unit of the Company in March 2016. He became Representative Director of the Company in March 2017, and currently serves as Representative Director, Executive Vice President; Chief Operating Officer and Head of the Japan Business Unit.
Research Interest
Molecular Biology and Molecular Genetics
